JMP Securities has recently reduced Agilon Health Inc (AGL) stock to Mkt Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on November 8, 2024, William Blair had reduced the stock from a Outperform to Mkt Perform. Citigroup also reduced Sell rating with a price target of $2.50. Additionally, BofA Securities reduced Underperform rating on October 2, 2024, with a target price of $3. Robert W. Baird analysts, in their report published on May 30, 2024, also initiated Neutral rating for Agilon Health Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Agilon Health Inc (AGL) Stock Trading Recap
On Friday, Agilon Health Inc (AGL) stock saw a modest uptick, ending the day at $2.16 which represents a slight increase of $0.05 or 2.37% from the prior close of $2.11. The stock opened at $2.13 and touched a low of $2.09 during the day, reaching a high of $2.21. The volume of shares traded was 2.84 million falling short of the average volume of 4.75 million.
Sponsored
AGL Stock Performance and Moving Averages
In recent trading, Agilon Health Inc (AGL) stock price has shown some volatility, fluctuating 21.35% over the last five trades and -12.20% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -65.71%, and it has plunged by -47.06% in the previous three months. Currently, AGL is trading at 3.13%, -21.69%, and -55.82% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, AGL, a Healthcare sector stock, is trading -84.30% below its 52-week high but remains 44.00% above its 52-week low. The Average True Range (ATR) (14 days) of 0.24 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Agilon Health Inc’s Profitability and Valuation Ratios
Agilon Health Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of -6.14% and a profit margin of -6.01%, with a gross margin of -65.71%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Agilon Health Inc’s market capitalization stands at $889.96 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 0.16, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 1.55, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 26.39% of Agilon Health Inc (AGL)’s shares, while financial institutions hold 80.53%.
